Life Science Sector in Reading

Reading is quickly becoming a powerhouse in the UK’s life sciences sector, strategically positioned within the ‘Golden Triangle’ - the UK’s most dynamic area for life sciences, spanning London, Oxford, and Cambridge. The region offers a vibrant ecosystem for life sciences businesses, from pharmaceuticals to biotechnology and cutting-edge AI applications in healthcare. With world-class research facilities, a thriving business community, and a growing network of life sciences clusters, Reading is the ideal location for similar companies looking to expand or relocate. 

State-of-the-art facilities & growing clusters 

The opening of the Thames Valley Science Park has marked a significant milestone in Reading’s rise as a life sciences hub. The park provides flexible office and laboratory spaces for growing businesses, with prominent tenants such as Menarini Pharma and Proton Partners already in place. This development, alongside emerging pharma clusters across various business parks in the area, provides an ideal environment for companies in pharma, biotech, and related fields to expand and grow. 

Green Park has become a key location for global life sciences and healthcare companies, attracting names like Bayer, PRA Health Sciences, Pierre Fabre, and Britannia Pharmaceuticals. Sanofi has also made a major move to Reading, establishing their operations at Thames Valley Park. Other notable life sciences companies, including IQVIA and BD, have also chosen Reading for their UK operations, positioning the area as a key destination for industry leaders. 

Research excellence & innovation 

Reading is home to the University of Reading, which plays a pivotal role in advancing life sciences research and education. The university’s Centre for Integrative Neuroscience and Neurodynamics (CINN) and the Institute for Cardiovascular and Metabolic Research (ICMR) are world-renowned for their groundbreaking work in neuroscience, cardiovascular health, and metabolic diseases. These research institutions not only contribute to scientific advancement but also help foster innovation and collaboration with local businesses, creating a dynamic environment for research-driven growth. 

Pharma, Biotech & AI 

Reading’s life sciences sector is continually evolving, with growing expertise in pharma, biotech, and artificial intelligence (AI). The region’s pharma sector is thriving, with major players in drug development, manufacturing, and distribution establishing a strong presence - and Biotech companies taking advantage of Reading's cutting-edge research and collaboration opportunities. 

AI is also becoming a key area of focus, with healthcare and life sciences companies leveraging artificial intelligence to revolutionise healthcare delivery. Reading’s combination of research expertise, business infrastructure, and AI-driven innovation makes it an attractive destination for companies operating at the intersection of life sciences and technology.